The Rise of Minor Cannabinoids Sets New Market Trends
Hemp-derived cannabinoids have gained a significant market share thanks to the 2018 Farm Bill and COVID-19. But CBD companies may ruin this progress with incompetent product creation.
From LSD to CBD, microdosing technology and legislation are making psychedelic drug therapies more accessible to mental health patients. And 21st-century companies are leading the destigmatization of hallucinogenics.